From 1997, the website also began to develop as a community repository, enabling researchers to deposit
data sets. Currently it maintains several
databases relating to
gene mutations, gene association studies,
epidemiological studies,
antibodies,
drug trials, protocols and antecedent biomarker studies. Of particular note are the AlzGene database of genetic studies of Alzheimer's disease, which has been cited more than 1,200 times in the scientific literature, and the AlzRisk database of epidemiologic studies. The forum acts as an integrator of these diverse sources, linking
primary research articles to related news, papers, databases, and discussions . From 2000 onwards, a data-driven dynamic system has been used to automatically search and download
PubMed citations into a database, and provide tools for editors to post news and comments and crosslink them to related material. The development of
semantic web tools is a current and ongoing development. These assist in the identification of hypotheses and related evidence in papers and discussions. SWAN (Semantic Web Applications in Neuromedicine) has resulted from a collaboration between the forum and
Massachusetts General Hospital. Work on this continues with the Scientific Collaboration Framework. The forum has become a point of reference for researchers into AD. As of June 2013 it has more than 8300 registered users. It is estimated that 30–50% of researchers from a wide range of institutions and countries studying Alzheimer's internationally are registered or active on the site. The success of Alzforum has resulted in its online disease-specific scientific community framework being cloned in other areas of research into
neurological disorders.
Multiple Sclerosis Discovery Forum,
Pain Research Forum,
Schizophrenia Research Forum and PD Online (a site for research into
Parkinson's disease, funded by the
Michael J. Fox Foundation) are using the same approach as Alzforum. ==References==